| Filed On | Filing |
|---|---|
| 03 Aug 2022 |
8-K/A: Results of Operations and Financial Condition; Regulation FD Disclosure
GAITHERSBURG, Md., August 1, 2022—Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2022. |
| 09 Sep 2021 |
8-K/A: Financial Statements and Exhibits
SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30 1. REQUISITION NO. 0000HCGE-2017-05523 PAGE 1 OF 28 2. CONTRACT NO. 200-2017-92634 3. AWARD/EFFECTIVE DATE 12/08/2016 4. ORDER NO. 5. SOLICI... |
| 01 May 2020 |
8-K/A: Results of Operations and Financial Condition; Regulation FD Disclosure
Executes multi-faceted response to COVID-19 drawing upon longstanding investments in capabilities to address public health threats, as well as expertise in vaccines, therapeutics, and contract development and manufacturing |
| 12 Dec 2018 |
8-K/A: Financial Statements and Exhibits
The following unaudited pro forma condensed combined financial statements of: |
| 12 Dec 2018 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying consolidated financial statements of Adapt Pharma Limited and its subsidiaries, which comprise the consolidated statements of financial position as of 31 December 2017 and 31 December 2016, and the relate... |
| 12 Dec 2013 |
8-K/A: Regulation FD Disclosure
December 11, 2013 Emergent BioSolutions Planned Acquisition ofCangene Corporation Provided December 11, 2013 as part of an oral presentation and is qualified by the entire presentation. This presentation contains forward-looking statemen... |
| 13 Jan 2011 |
8-K/A: Completion of Acquisition or Disposition of Assets
Statements of Operations for the Three and Six Months Ended June 30, 2010 and 2009 |
| 16 Aug 2010 | 8-K/A: Other Events |
| 23 Oct 2007 |
8-K/A: Results of Operations and Financial Condition
EMERGENT BIOSOLUTIONS COMPLETES FIRST DELIVERY OF BIOTHRAX(r) (ANTHRAX VACCINE ADSORBED) TO THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER NEW CONTRACT |
Loading...